Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Oral Oncol. 2019 Jun 7;95:52–58. doi: 10.1016/j.oraloncology.2019.06.002

Table 5-.

Factors predictive of recurrence-free survival

Factor Variable No. of Patients 5-year RFSa Univariate
HRb CIc p-value
Age ≤60 27 90%
>60 30 96% 0.831 0.147–4.714 0.834
Sex Female 37 92%
Male 20 94% 4.589 0.826–25.487 0.057
Alcohol Never 18 100%
Ever 38 89% 2.725 0.317–23.402 0.341
Tobacco Never 17 83%
Ever 39 94% 0.604 0.109–3.332 0.558
Site Minor 54 92%
Major 3 100% --- --- 0.751
pTd Status T1/T2 51 94%
T3/T4 6 75% 6.419 0.545–75.592 0.091
pNe Status NO/X 51 91%
N+ 6 100% 1.994 0.222–17.924 0.530
Overall I/II 47 94%
pathologic stage III/IV 10 88% 4.308 0.701–26.484 0.087
Vascular No 53 92%
invasion Yes 2 100% --- --- 0.588
Perineural invasion No 18 86%
Yes 37 97% 0.267 0.048–1.472 0.104
Histology PACf 32 92%
CAMSGg 14 100% 2.926 0.473–18.080 0.228
Margin Negative 27 95%
Close /Positive 29 89% 0.596 0.108–3.270 0.547
PORTh No 44 92%
Yes 13 92% 1.921 0.316–11.666 0.471
a-

RFS, recurrence-free survival;

b-

HR, hazard ratio;

c-

CI, confidence interval;

d-

pT, pathological tumor;

e-

pN, pathological nodal;

f-

PAC, polymorphous adenocarcinoma;

g-

CAMSG, cribriform adenocarcinoma of minor salivary gland origin;

h-

PORT, postoperative radiotherapy